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Scope of Problem 
• Addiction “recovery” or “success” has historically focused on 
survivorship, relapse, and maintenance medication 
discontinuation/detox as outcome measures. There is little 
standardization or tracking of broader measures in the US (1) 
• VT has significantly expanded access to Medication Assisted 
Treatment (MAT) programs, but little is known yet about the 
trajectory of suboxone patients or tapering process in our 
particular population (2, 3). National data reveals only 10-50% 
abstinence following detox, but suggests length of taper and lower 
mean maintenance dose may predict “successful” detox (4).
• Given this uncertainty, providers and patients must reframe their 
understanding of treatment “success” to appreciate overall social 
and medical stabilization, despite a plateau in suboxone dose 
taper or prospect of indefinite treatment
• A 20-question, interactive “POWERS Form” has been developed 
by Stowe’s MAT team as part of routine counseling and clinical 
visits. Tracking score changes with patients allows reflection on 
the broader life changes during recovery process. This activity 
can perhaps challenge harmful perceptions of pharmacotherapy 
as either a “silver bullet”, indefinite crutch, or sign of failure
Status of VT Epidemic and Hub & Spoke Program
• As of Jan 2018, 228 patients were on maintenance 
medication in Lamoille Region with 0 on waitlist
• Number of prescribers has doubled from 7 to 14 in 
Lamoille since 2014, but Dr. Marvin is only 1 of 4 
providers that see more than 10 MAT patients (2)
• She estimates about 1/3 of her patient visits are MAT
• Several tools already exist and are available to guide 
clinicians in determining the appropriateness of Hub 
vs. Spoke placement (ex, Stability Index), but these 
do not necessarily aid in patient-provider interaction 
or patient reflection (3).
• In 2017, 70% of Spoke patients cited their
relationship with their prescribing doctor as the 
most important element of their treatment journey 
(5), emphasizing need for options in choosing a 
prescriber
Contacts & Community Perspective
• Stowe Family Practice MAT Team would like to formally validate the 
POWERS form and give a poster presentation at the 2018 Family 
Medicine state meeting. Promoting its use could empower more FM 
providers to become prescribers and further destigmatize long-term 
suboxone treatment
• Established prescribers/known MAT advocates at Burlington-area 
community health center report that for their own use, they have 
tracked certain social markers for individual MAT patients in notes and 
spreadsheets, but not in any formalized way
Methodology
• PubMed search for existence and/or
evaluation of similar tools used at the state,
national, and international level
• Review of latest state-level data for context
• Medical student immersion into MAT
counseling sessions and provider meetings 
to allow insight into use of POWERS tool 
and individual patient journeys to stability 
• Data cleaning, entry, and organization in 
Excel to prepare descriptive statistics for 
poster, but also to lay groundwork for future 
analysis
• Informal correspondence with established
prescribing FM physicians at community
health centers and with evaluation experts 
at the Jefferson Institute 
Results
• Validity of tool: POWERS form question 
content consistent with: 
• “Domains of life functioning” identified & 
used in 2017 Hub & Spoke evaluation (5)
• “Indicators of recovery” identified in large-
scale studies of Australian providers (6)
• Components of well-established WHO 
Quality of Life index tool (7)
• Preliminary Data: Mean score change 
over course of treatment (max 
score=100): 36.75 points
• Greatest change in domains pertaining to 
coping, overall med compliance, and 
confidence in sobriety.
• Smallest changes seen in access to resources 
such as insurance, safe living spaces, or 
childcare. 
Question Domain Mean Domain Change
Coping with stress 2.46
Medication adherence 2.29







Sobriety of contacts 1.71
Counseling groups or sponsor 1.71








Working phone number 0.88
Spiritual or Religious practice 0.88
Legal compliance (DCF, Parole) 0.83
Safe place to Live 0.79
Health insurance 0.54
Childcare 0.38
Evaluation of Effectiveness & Limitations
• Small sample size (n=24) of patients with >2 POWERS scores limits options for further data 
analysis at this time
• Scores in domains for legal compliance and childcare access were likely artificially raised at 
initial score due to blank score conversion to 4/4 to preserve total score=100. MAT team 
should communicate to standardize how to classify “irrelevant” or blank domain scores in 
a way that will allow better representation of true changes
• Without integration of form into EHR or designating a team member to maintain data, 
long-term compilation may not be feasible. Also, there may be missed opportunities to 
collect additional information on treatment timelines and relapse events
• The “organic” emergence of tool and its content suggests that it is rooted in valuable 
patient and provider experience, but there has been little documentation of revision 
process 
• Emerging connection and collaboration between Jeffords Institute and Stowe providers 
should yield process for validation/evaluation of form that would be realistic within a busy 
clinical setting 
Recommendations
• Continue connection with Jeffords Institute to capitalize on their expertise, 
as well as to increase visibility of tool and its purpose 
• Formalize process of tool revision, perhaps via focus groups with more 
prescribers, current patients, or with patients exiting MAT. These could be 
vital opportunities to receive feedback on POWERS form content, ease of 
use, and impact on patient experience
• Potentially arrange future pilot of POWERS form at Burlington CBHC’s to
gain provider perspective and gauge its use in a different patient 
subpopulation
• Poster presentation is a reasonable first step to expand use of tool to other 
FM providers, uncover similar tools or processes currently in use at other 
clinics, and empower FM providers to become waivered prescribers 
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